Signal Detection Is Only as Good as the Data Infrastructure Behind It
Pharmacovigilance signal detection has moved from a primarily reactive discipline—reviewing spontaneous adverse event reports—to a proactive, multi-source surveillance operation. Under ICH E2E guidelines and EMA's Good Pharmacovigilance Practice (GVP) Module IX, marketing authorization holders must conduct systematic signal detection across spontaneous reports, published literature, electronic health records, and post-authorization safety study data.
According to the European Medicines Agency's 2024 Annual Report, EMA's Pharmacovigilance Risk Assessment Committee (PRAC) assessed 181 signals in 2024, resulting in 62 label updates and 14 product risk minimization measure changes. Behind each of these regulatory actions is a data infrastructure that requires continuous maintenance—literature monitoring, case source surveillance, aggregate data collection—and a coordination layer that routes the right information to safety scientists at the right time.
For drug safety departments and pharmacovigilance consulting firms, that coordination layer is increasingly handled by virtual assistants with PV administrative experience.
Literature Monitoring Coordination: A High-Volume, Time-Sensitive Workflow
ICH E2D and GVP Module VI require marketing authorization holders to conduct systematic searches of scientific literature for potential adverse drug reaction reports. The standard is a weekly search across at least the major literature databases (Embase, MEDLINE), with expedited review of any identified case reports that might meet criteria for individual case safety report (ICSR) submission.
The administrative workflow surrounding literature monitoring is substantial. A VA can manage the search calendar, coordinate with the literature monitoring vendor or in-house information specialist to confirm weekly search completion, maintain the triage log of identified articles, route potential case reports to the qualified safety scientist for medical review, and track the outcome of each article review through to ICSR submission or documented exclusion. This coordination ensures that no weekly search cycle falls behind and that article triage is systematically documented—both priorities in health authority inspections of PV systems.
PBRER Data Collection: Compiling Aggregate Safety Data Under Deadline Pressure
Periodic Benefit-Risk Evaluation Reports (PBRERs), formerly PSURs, are among the most demanding deliverables in pharmacovigilance. These aggregate safety reports, submitted to EMA and other regulatory authorities on defined schedules (annual, three-year, or other intervals), require compilation of data from multiple sources: cumulative case counts by MedDRA term, literature surveillance summaries, post-authorization safety study updates, risk minimization effectiveness data, and the safety scientist's benefit-risk assessment narrative.
Assembling this data from disparate sources—the safety database, the literature monitoring system, the regulatory affairs team, post-authorization study vendors—is a significant project management exercise. A VA can own the PBRER data collection workflow: building and maintaining a master data request tracker, sending timed data requests to each source system owner, compiling received data into the report structure template, and tracking outstanding items for the writing team. This coordination role keeps the PBRER on schedule without requiring the safety scientist to spend hours chasing data submissions.
EMA Query Management: Responding to Regulatory Scrutiny on Time
When EMA or a national competent authority issues a query related to a PBRER, signal assessment, or routine pharmacovigilance inspection finding, the marketing authorization holder must respond within a defined timeline—often 15 to 30 days. These queries require pulling supporting documentation, coordinating responses from safety, regulatory, and medical affairs teams, and submitting a formatted response through the appropriate regulatory portal.
A VA can support the EMA query response process by maintaining a query tracker, coordinating internal document requests, formatting draft response packages per EMA submission conventions, and managing the portal submission workflow. For PV consulting firms managing query responses on behalf of multiple MAH clients, this coordination support is particularly valuable for maintaining client response timelines across a portfolio.
PV teams and drug safety consulting firms ready to build this administrative layer can explore experienced candidates at Stealth Agents.
Sources
- European Medicines Agency. Annual Report 2024. ema.europa.eu
- ICH. E2E: Pharmacovigilance Planning. ich.org
- EMA. Good Pharmacovigilance Practices (GVP) Module IX: Signal Management. ema.europa.eu